Blue Ribbon recommends charges vs Yang, Pharmally, DBM-PS over COVID fund mess

Blue Ribbon recommends charges vs Yang, Pharmally, DBM-PS over COVID fund mess

Detalhes bibliográficos
Publicado no:Manila Bulletin Vol. 586, no. 20 (20 Oct. 2021), 10
Autor principal: Torregoza, Hannah L.
Formato: Artigo
Publicado em: 2021
Assuntos:
Philippines. Congress. Senate. Blue Ribbon Committee
COVID-19 pandemic > Finance > Investigations
Pharmally Pharmaceutical Corporation > Officials and employees
Philippines. Department of Budget and Management. Procurement Service > Officials and employees